登士柏西诺德

最新新闻

• 评级变动
  BofA Securities Maintains Dentsply Sirona(XRAY.US) With Buy Rating, Maintains Target Price $17
  \u5e02\u573a\u8d44\u8baf · 2026/6/12
• 评级变动
  Mizuho Securities Maintains Dentsply Sirona(XRAY.US) With Hold Rating, Cuts Target Price to $14
  \u5e02\u573a\u8d44\u8baf · 2026/5/7
• 评级变动
  Citi Initiates Dentsply Sirona(XRAY.US) With Sell Rating, Announces Target Price $10
  \u5e02\u573a\u8d44\u8baf · 2026/4/15
• 评级变动
  Piper Sandler Maintains Dentsply Sirona(XRAY.US) With Hold Rating, Maintains Target Price $13
  \u5e02\u573a\u8d44\u8baf · 2026/5/4
• 评级变动
  Piper Sandler Maintains Dentsply Sirona(XRAY.US) With Hold Rating, Raises Target Price to $14
  \u5e02\u573a\u8d44\u8baf · 2026/7/29
• 评级变动
  Barrington Maintains Dentsply Sirona(XRAY.US) With Buy Rating, Maintains Target Price $17
  \u5e02\u573a\u8d44\u8baf · 2026/5/6
• 评级变动
  Citi Maintains Dentsply Sirona(XRAY.US) With Sell Rating, Maintains Target Price $10
  \u5e02\u573a\u8d44\u8baf · 2026/4/16
• BMO Capital Maintains Dentsply Sirona(XRAY.US) With Hold Rating, Cuts Target Price to $10
  \u5e02\u573a\u8d44\u8baf · 2026/9/17
• 评级变动
  Barclays Maintains Dentsply Sirona(XRAY.US) With Sell Rating, Maintains Target Price $9
  \u5e02\u573a\u8d44\u8baf · 2026/6/5
• A Quick Look at Today's Ratings for Dentsply Sirona(XRAY.US), With a Forecast Between $9 to $15
  \u5e02\u573a\u8d44\u8baf · 2026/8/8
• 评级变动
  A Quick Look at Today's Ratings for Dentsply Sirona(XRAY.US), With a Forecast Between $10.5 to $17
  \u5e02\u573a\u8d44\u8baf · 2026/5/6
• 评级变动
  Morgan Stanley Maintains Dentsply Sirona(XRAY.US) With Hold Rating
  \u5e02\u573a\u8d44\u8baf · 2026/7/24
• J.P. Morgan Maintains Dentsply Sirona(XRAY.US) With Hold Rating, Announces Target Price $12
  \u5e02\u573a\u8d44\u8baf · 2026/9/17
• DENTSPLY SIRONA (XRAY) Receives a Hold From J.P. Morgan
  TipRanks · 2026/9/17
• 评级变动
  BMO Capital Maintains Dentsply Sirona(XRAY.US) With Hold Rating, Maintains Target Price $12
  \u5e02\u573a\u8d44\u8baf · 2026/7/10
• 评级变动
  Analysts Offer Insights on Healthcare Companies: Tempus AI, Inc. Class A (TEM), Protagonist Therapeutics (PTGX) and DENTSPLY SIRONA (XRAY)
  TipRanks · 2026/5/6
• 评级变动
  Barclays Maintains Dentsply Sirona(XRAY.US) With Sell Rating, Cuts Target Price to $9
  \u5e02\u573a\u8d44\u8baf · 2026/6/4
• 评级变动
  UBS Maintains Dentsply Sirona(XRAY.US) With Buy Rating, Cuts Target Price to $17
  \u5e02\u573a\u8d44\u8baf · 2026/5/7
• Barrington Maintains Dentsply Sirona(XRAY.US) With Buy Rating, Cuts Target Price to $15
  \u5e02\u573a\u8d44\u8baf · 2026/8/10
• 评级变动
  Leerink Partners Maintains Dentsply Sirona(XRAY.US) With Hold Rating
  \u5e02\u573a\u8d44\u8baf · 2026/6/12

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。